These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16388850)

  • 1. Aven overexpression: association with poor prognosis in childhood acute lymphoblastic leukemia.
    Choi J; Hwang YK; Sung KW; Kim DH; Yoo KH; Jung HL; Koo HH
    Leuk Res; 2006 Aug; 30(8):1019-25. PubMed ID: 16388850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia.
    Yang YL; Lin SR; Chen JS; Lin SW; Yu SL; Chen HY; Yen CT; Lin CY; Lin JF; Lin KH; Jou ST; Hu CY; Chang SK; Lu MY; Chang HH; Chang WH; Lin KS; Lin DT
    Leuk Res; 2010 Jan; 34(1):18-23. PubMed ID: 20109966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of t(12;21)(p13;q22) in children with acute lymphoblastic leukemia and known clinical outcome in southern Brazil.
    Veiga LB; Cóser VM; Cavalli LR; Cavalli IJ; Rodrigues JN; Pereira WV; Pereira DV; Lafayette TC; Villalba BT; Moreira ME; Haddad BR; de Souza Fonseca Ribeiro EM
    Leuk Res; 2004 Oct; 28(10):1033-8. PubMed ID: 15289014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.
    Eißmann M; Melzer IM; Fernández SB; Michel G; Hrabě de Angelis M; Hoefler G; Finkenwirth P; Jauch A; Schoell B; Grez M; Schmidt M; Bartholomae CC; Newrzela S; Haetscher N; Rieger MA; Zachskorn C; Mittelbronn M; Zörnig M
    Oncogene; 2013 May; 32(20):2586-91. PubMed ID: 22751129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Heerema NA; Sather HN; Sensel MG; Lee MK; Hutchinson R; Nachman JB; Lange BJ; Steinherz PG; Bostrom B; Gaynon PS; Uckun FM
    Cancer; 2000 Apr; 88(8):1945-54. PubMed ID: 10760773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL).
    Mata JF; Silveira VS; Mateo EC; Cortez MA; Queiroz RG; Yunes JA; Lee ML; Toledo SR; Petrilli AS; Brandalise SR; Tone LG; Scrideli CA
    Pediatr Blood Cancer; 2010 Jul; 55(1):100-7. PubMed ID: 20232432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.
    Wu S; Gessner R; von Stackelberg A; Kirchner R; Henze G; Seeger K
    Cancer; 2005 Mar; 103(5):1054-63. PubMed ID: 15651075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia.
    Gottardo NG; Hoffmann K; Beesley AH; Freitas JR; Firth MJ; Perera KU; de Klerk NH; Baker DL; Kees UR
    Br J Haematol; 2007 May; 137(4):319-28. PubMed ID: 17456054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features.
    de Oliveira JC; Scrideli CA; Brassesco MS; Morales AG; Pezuk JA; Queiroz Rde P; Yunes JA; Brandalise SR; Tone LG
    Leuk Res; 2012 Mar; 36(3):293-8. PubMed ID: 22099053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival.
    Forestier E; Heyman M; Andersen MK; Autio K; Blennow E; Borgström G; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kerndrup G; Nordgren A; Rosenquist R; Swolin B; Johansson B; ; ;
    Br J Haematol; 2008 Mar; 140(6):665-72. PubMed ID: 18241254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and cytogenetic features in childhood acute lymphoblastic leukemia with 1; 19 translocation].
    Sikano T; Ishikawa Y; Konno M; Hatayama Y; Nakadate H; Hatae Y; Takeda T
    Rinsho Ketsueki; 1990 Jun; 31(6):793-8. PubMed ID: 2214170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962.
    Avramis IA; Panosyan EH; Dorey F; Holcenberg JS; Avramis VI;
    Clin Cancer Res; 2006 Dec; 12(23):6978-84. PubMed ID: 17145817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of interleukin-10 splicing variants is a positive prognostic feature in relapsed childhood acute lymphoblastic leukemia.
    Wu S; Gessner R; Taube T; von Stackelberg A; Henze G; Seeger K
    J Clin Oncol; 2005 May; 23(13):3038-42. PubMed ID: 15860861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia.
    Choi J; Hwang YK; Sung KW; Lee SH; Yoo KH; Jung HL; Koo HH; Kim HJ; Kang HJ; Shin HY; Ahn HS
    Blood; 2007 Jan; 109(2):471-7. PubMed ID: 16990595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperdiploidy (greater than 50 chromosomes) has the most favorable prognosis among the major karyotypic subgroups of childhood acute lymphoblastic leukemia].
    Shikano T; Ishikawa Y; Kobayashi R; Konno M; Hatayama Y; Nakadate H; Hatae Y; Takeda T
    Rinsho Ketsueki; 1990 Mar; 31(3):308-14. PubMed ID: 2366333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia.
    Kirschner-Schwabe R; Lottaz C; Tödling J; Rhein P; Karawajew L; Eckert C; von Stackelberg A; Ungethüm U; Kostka D; Kulozik AE; Ludwig WD; Henze G; Spang R; Hagemeier C; Seeger K
    Clin Cancer Res; 2006 Aug; 12(15):4553-61. PubMed ID: 16899601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index.
    Hoffmann K; Firth MJ; Beesley AH; Freitas JR; Ford J; Senanayake S; de Klerk NH; Baker DL; Kees UR
    Br J Haematol; 2008 Mar; 140(6):656-64. PubMed ID: 18302714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognosis markers in pediatric high-risk acute lymphoblastic leukemia.
    Al-Lamki Z; Wali YA; Wasifuddin SM; Zachariah M; Al-Mjeni R; Li C; Muralitharan S; Al-Kharusi K; Gunaratne P; Peterson L; Gibbs R; Gingras MC; Margolin JF
    Pediatr Hematol Oncol; 2005; 22(7):629-43. PubMed ID: 16166056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.